Heart Failure with Preserved Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Preserved Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-09Clinical Trial Update: Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy [Phase 2]
Phase 2 trial evaluating the reverse remodeling effects of the investigational drug CDR132L in patients with heart failure with preserved ej…
-
CLINICAL_TRIALS withdrawal · 2025-05-15Clinical Trial Update: Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction [Phase 2]
A Phase 2 trial evaluating the selective PDE9 inhibitor IMR-687 for heart failure with preserved ejection fraction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Rivet PVS Therapy in Group 2 PH-HFpEF Canada [NA]
The Rivet PVS Therapy trial in Group 2 pulmonary hypertension associated with heart failure with preserved ejection fraction (HFpEF) in Cana…
-
CLINICAL_TRIALS withdrawal · 2022-07-28Clinical Trial Update: Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction [Phase 4]
A Phase 4 trial evaluating ferric carboxymaltose for iron deficiency in heart failure with preserved ejection fraction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-05-10Clinical Trial Update: Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus [Phase 4]
A Phase 4 trial evaluating Polydiuretic Therapy for heart failure with preserved ejection fraction and diabetes mellitus has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-08-30Clinical Trial Update: Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction [Phase 3]
Phase 3 trial investigating sacubitril/valsartan for myocardial oxygenation and fibrosis in heart failure with preserved ejection fraction w…
-
CLINICAL_TRIALS withdrawal · 2018-04-19Clinical Trial Update: Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF [NA]
A clinical trial evaluating rate-adaptive pacing for chronotropic response in heart failure with preserved ejection fraction has been withdr…
-
CLINICAL_TRIALS withdrawal · 2016-03-30Clinical Trial Update: Exercise Training in Treating Diastolic Heart Failure [NA]
Clinical trial NCT02155842 evaluating exercise training for diastolic heart failure was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-12Clinical Trial Update: Aliskiren and Renin Inhibition in Diastolic Heart Failure [NA]
A clinical trial evaluating aliskiren, a renin inhibitor, for heart failure with preserved ejection fraction (diastolic heart failure) has b…
-
CLINICAL_TRIALS withdrawal · 2014-11-25Clinical Trial Update: If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure [Phase 2]
A Phase 2 study evaluating ivabradine for diastolic heart failure has been withdrawn.